Human Prostatic Cancer Organoid

Description

Human prostatic cancer organoids are patient-derived 3D tumor models that preserve the histological and genetic characteristics of prostate cancer, including tumor heterogeneity and clinically relevant mutations. These organoids provide robust in vitro platforms for investigating prostate cancer biology, androgen signaling, resistance mechanisms, and therapeutic responses. With long-term expansion and cryopreservation capability, they are suitable for applications in cancer disease modeling, biomarker discovery, drug screening, and the development of precision medicine strategies in urologic oncology.